Judge Rules in Favor of FDA in Ranbaxy Drug Approval Suit
U.S. District Judge Beryl Howell ruled that the FDA is within its right torevoke approval of Ranbaxy's generic Nexium and Valcyte. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - March 17, 2015 Category: Pharmaceuticals Source Type: news
Ranbaxy loses approvals, exclusivity of two drugs in US
In November, Ranbaxy had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 3, 2015 Category: Pharmaceuticals Source Type: news
US judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies
Launching the first generic copies of the drugs would have given Ranbaxy six months of exclusivity on the market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 28, 2015 Category: Pharmaceuticals Source Type: news
U.S. judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies
MUMBAI (Reuters) - A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium and the antiviral Valcyte, a court document showed. (Source: Reuters: Health)
Source: Reuters: Health - February 28, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
Morning Break: Califf to FDA; Generic Nexium; Another Clinic Shooting
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 27, 2015 Category: Primary Care Source Type: news
Ranbaxy forfeits 180 days exclusivity for generic Nexium
Ranbaxy said USFDA has determined that it has forfeited its 180-day exclusivity to sell generic version of digestive disorder medicine Nexium in US market (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2015 Category: Pharmaceuticals Source Type: news
Generic Form of Nexium Approved
Title: Generic Form of Nexium ApprovedCategory: Health NewsCreated: 1/26/2015 12:00:00 AMLast Editorial Review: 1/27/2015 12:00:00 AM (Source: MedicineNet Crohn's Disease General)
Source: MedicineNet Crohn's Disease General - January 27, 2015 Category: Gastroenterology Source Type: news
First Generic Nexium Approved (FREE)
By The Editors
The FDA has approved the first generic version of the proton-pump inhibitor … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 27, 2015 Category: Primary Care Source Type: news
FDA OKs First Generic Version of Heartburn Drug Nexium
The proton pump inhibitor reduces amount of acid in the stomach (Source: WebMD Health)
Source: WebMD Health - January 26, 2015 Category: Consumer Health News Source Type: news
FDA OKs First Generic Version of Heartburn Drug Nexium
The proton pump inhibitor reduces amount of acid in the stomach
Source: HealthDay
Related MedlinePlus Pages: GERD, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 26, 2015 Category: Consumer Health News Source Type: news
FDA Clears First Generic Esomeprazole for GERDFDA Clears First Generic Esomeprazole for GERD
Ivax Pharmaceuticals, Inc, a subsidiary of Teva Pharmaceuticals USA, will market esomeprazole in 20- and 40-mg capsules. FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 26, 2015 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news
FDA approves Teva's generic version of AstraZeneca's Nexium
(Reuters) - The U.S. Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug. (Source: Reuters: Health)
Source: Reuters: Health - January 26, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
FDA approves first generic esomeprazole
The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages 1 and older. Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach. (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 26, 2015 Category: American Health Source Type: news
AstraZeneca's Move to Protect Nexium Market Ruled Legal
(MedPage Today) -- "Pay to delay" strategy upheld by court. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 9, 2014 Category: American Health Source Type: news
Boston court rules in favor of AstraZeneca's 'pay-for-delay' deal involving Nexium
A federal jury in Massachusetts has ruled in favor of AstraZeneca Plc and Ranbaxy Laboratories following accusations that the companies delayed the launch of a generic version of the heartburn drug Nexium, sparing the companies potentially billions in damages.
The verdict was handed down Friday in federal court in Boston.
The lawsuit began in 2012 and was filed by plaintiffs including drug wholesalers, retailers and insurance companies. The plaintiffs claimed that the two companies agreed to a… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 7, 2014 Category: Biotechnology Authors: Mary Moore Source Type: news
